Similar articles

• Cholecystokinin octapeptide exerts its therapeutic effects on collagen-induced arthritis by suppressing both inflammatory and Th17 responses.

  Li Q, Cong B, Shan B, Zhang J, Chen H, Wang T, Ma C, Qin J, Wen D, Yu F. Li Q, et al. Rheumatol Int. 2011 Oct;31(10):1291-8. doi: 10.1007/s00296-010-1476-4. Epub 2010 Apr 8. Rheumatol Int. 2011. PMID: 20376668
• Cholecystokinin octapeptide significantly suppresses collagen-induced arthritis in mice by inhibiting Th17 polarization primed by dendritic cells.

  Li Q, Han D, Cong B, Shan B, Zhang J, Chen H, Ma C, Liyanage SS. Li Q, et al. Cell Immunol. 2011;272(1):53-60. doi: 10.1016/j.cellimm.2011.09.007. Epub 2011 Sep 29. Cell Immunol. 2011. PMID: 22004797
• Effects of anti-arthritic drugs on IL-1 induced inflammation in rats.

  Hrubey PS, Harvey AK, Bendele AM, Chandrasekhar S. Hrubey PS, et al. Agents Actions. 1991 Sep;34(1-2):56-9. doi: 10.1007/BF01993237. Agents Actions. 1991. PMID: 1793051
• Cholecystokinin octapeptide (CCK-8): a negative feedback control mechanism for opioid analgesia.

  Han JS. Han JS. Prog Brain Res. 1995;105:263-71. doi: 10.1016/s0079-6123(08)63303-8. Prog Brain Res. 1995. PMID: 7568886 Review. No abstract available.
• Mechanisms of action of methotrexate.

  Genestier L, Paillot R, Quemeneur L, Izeradjene K, Revillard JP. Genestier L, et al. Immunopharmacology. 2000 May;47(2-3):247-57. doi: 10.1016/s0162-3109(00)00189-2. Immunopharmacology. 2000. PMID: 10878292 Review. No abstract available.